Female sexual arousal disorder (FSAD) describes a recurrent or persistent difficulty in becoming sexually excited or maintaining sexual arousal during sexual activity, despite adequate stimulation and the desire to engage in sex. When these problems cause personal distress or strain a relationship, they are considered a form of female sexual dysfunction. FSAD affects a wide range of adults and may be temporary or long-term; its impact depends on severity, frequency, and the emotional or relational consequences for the individual.
Key characteristics and symptoms
Symptoms of FSAD vary, but common features include reduced genital or subjective sexual excitement, diminished lubrication, decreased sensation, and an inability to sustain arousal long enough to enjoy sexual activity. A clinical diagnosis typically requires that the problem be present for several months and that it causes significant distress. Assessment distinguishes whether desire (libido), arousal, orgasm, or pain are the primary issues, because women commonly experience more than one type of sexual difficulty.
- Subjective symptoms: low feelings of sexual excitement, lack of mental sexual interest.
- Physical signs: inadequate clitoral or vaginal engorgement, insufficient lubrication.
- Associated features: anxiety about sexual performance, avoidance of intimacy, lowered relationship satisfaction.
Causes and contributing factors
FSAD usually arises from an interaction of physical, psychological, interpersonal, and contextual influences. Physical factors can include hormonal changes (for example during menopause or after childbirth), chronic illnesses, neurological or vascular conditions, and side effects of medications (notably some antidepressants and hormonal agents). Psychological contributors include depression, anxiety, past sexual trauma, body image concerns, and stress. Relationship issues—such as poor communication, unresolved conflict, or lack of emotional closeness—also frequently play a central role.
- Biological: hormonal shifts, medical illness, pain disorders.
- Psychological: mood disorders, stress, sexual trauma.
- Relational and social: partner factors, cultural attitudes, life transitions.
Diagnosis and clinical evaluation
Evaluation begins with a detailed sexual, medical, and medication history, and may include standardized questionnaires, a physical pelvic examination, and targeted laboratory tests (for hormonal or metabolic contributors). Diagnosis follows accepted criteria that emphasize both symptom duration and the presence of distress. Clinicians may consult specialist guidance or reviews for assessment frameworks and treatment pathways clinical review.
Treatment approaches and management
Management is individualized and often multidisciplinary. Nonpharmacologic options include sexual education, cognitive-behavioral therapy (CBT), sex therapy, couples counseling, pelvic floor rehabilitation, and behavioral exercises to increase sexual responsiveness. Medical options can include adjusting medications that impair sexual function, topical estrogen for menopausal atrophy, or other hormonal therapies when appropriate. Some pharmacologic treatments are used off-label or are evidence-limited; shared decision-making about risks and benefits is essential. Referral to gynecology, psychiatry, urology, or a certified sex therapist is common.
- Psychotherapy and sex therapy: address anxiety, trauma, and relational issues.
- Medical measures: treat underlying medical conditions and consider hormonal therapy when indicated.
- Lifestyle changes: reduce alcohol and tobacco use, manage stress, improve sleep and exercise.
History, classification, and notable distinctions
Historically, diagnostic categories for female sexual difficulties have evolved. Earlier classifications separated desire and arousal disorders; recent diagnostic systems combine interest and arousal in recognition of overlap between mental and physical aspects. It is important to distinguish FSAD from related conditions such as low sexual desire, orgasmic disorder, and sexual pain disorders, because treatments differ. For clinicians and patients seeking further resources on classification, assessment tools, and multidisciplinary care models, authoritative sources and guideline summaries can be consulted diagnostic guidance and treatment overview.
Because prevalence estimates vary by population and measurement method, exact figures are uncertain; what is clear is that sexual difficulties are common and often treatable. Early, nonjudgmental discussion with a healthcare provider and a tailored, biopsychosocial approach improve the chances of meaningful benefit. For patient-oriented information and support networks, see accessible resources and educational materials resources for patients.